Insider Transactions in Q1 2023 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$437,500
$35.05 P/Share
|
|
Mar 28
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Mar 15
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.26 P/Share
|
|
Mar 15
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Mar 09
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.28%
|
$156,000
$39.1 P/Share
|
|
Mar 06
2023
|
Ching Jaw SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+25.57%
|
-
|
|
Mar 06
2023
|
Fady Ibraham Malik EVP Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+18.59%
|
-
|
|
Mar 06
2023
|
Robert Wong VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+17.85%
|
-
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+15.76%
|
-
|
|
Mar 06
2023
|
Andrew Callos EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+35.85%
|
-
|
|
Mar 06
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,403
-4.02%
|
$93,717
$39.13 P/Share
|
|
Mar 06
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,958
-3.54%
|
$193,362
$39.13 P/Share
|
|
Mar 06
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
692
-3.1%
|
$26,988
$39.13 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,900
-3.21%
|
$464,100
$39.13 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-3.26%
|
$487,500
$39.94 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.16%
|
$112,500
$9.65 P/Share
|
|
Mar 02
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,484
-10.02%
|
$96,876
$39.6 P/Share
|
|
Mar 02
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
10,785
-7.15%
|
$420,615
$39.6 P/Share
|
|
Mar 02
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,225
-9.44%
|
$242,775
$39.6 P/Share
|
|
Mar 02
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,724
-8.12%
|
$1,276,236
$39.6 P/Share
|
|
Mar 02
2023
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-8.51%
|
$85,878
$39.6 P/Share
|
|
Feb 21
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,234
-8.27%
|
$100,530
$45.21 P/Share
|
|
Feb 16
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-1.85%
|
$22,440
$44.13 P/Share
|
|
Feb 16
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-1.8%
|
$53,240
$44.13 P/Share
|
|
Feb 16
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-0.99%
|
$66,572
$44.13 P/Share
|
|
Feb 16
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,230
-0.79%
|
$142,120
$44.13 P/Share
|
|
Feb 16
2023
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-3.61%
|
$42,636
$44.13 P/Share
|
|
Feb 10
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Bona fide gift
|
Direct |
150
-0.1%
|
-
|
|
Feb 09
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
11,000
-3.42%
|
$473,000
$43.74 P/Share
|
|
Feb 09
2023
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.1%
|
$49,000
$7.96 P/Share
|
|
Feb 06
2023
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
7,000
-35.84%
|
$315,000
$45.0 P/Share
|
|
Feb 06
2023
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+26.38%
|
$42,000
$6.72 P/Share
|
|
Feb 03
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
15,000
-18.25%
|
$675,000
$45.0 P/Share
|
|
Feb 03
2023
|
Ching Jaw SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+15.43%
|
$180,000
$12.1 P/Share
|
|
Feb 03
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,004
-9.84%
|
$135,180
$45.0 P/Share
|
|
Jan 17
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$420,000
$42.43 P/Share
|
|
Jan 17
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Jan 12
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.49%
|
$160,000
$40.47 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$440,000
$44.24 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Jan 03
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.98%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+1.08%
|
$5,544
$44.35 P/Share
|
|
Jan 03
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+4.6%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.9%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.98%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.78%
|
$19,800
$44.35 P/Share
|